132 related articles for article (PubMed ID: 3083539)
41. Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones.
Fazekas de St Groth B; Gallagher PF; Miller JF
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2594-8. PubMed ID: 3085100
[TBL] [Abstract][Full Text] [Related]
42. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.
Sprent J; Schaefer M; Lo D; Korngold R
Immunol Rev; 1986 Jun; 91():195-218. PubMed ID: 2942460
[TBL] [Abstract][Full Text] [Related]
43. Effect of organ culture on the survival of thyroid allografts in mice.
Lafferty KJ; Bootes A; Dart G; Talmage DW
Transplantation; 1976 Aug; 22(2):138-49. PubMed ID: 61634
[TBL] [Abstract][Full Text] [Related]
44. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
Wheelahan J; McKenzie IF
Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
[TBL] [Abstract][Full Text] [Related]
45. Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2K characterizes the cell-mediated potential for disease expression: susceptible mice provide a unique effector T cell repertoire in response to tubular antigen.
Neilson EG; McCafferty E; Mann R; Michaud L; Clayman M
J Immunol; 1985 Apr; 134(4):2375-82. PubMed ID: 2579142
[TBL] [Abstract][Full Text] [Related]
46. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
47. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
Huston DP; Tavana G; Rich RR; Gressens SE
J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
[TBL] [Abstract][Full Text] [Related]
48. Sensitized Lyt-2+ T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens.
Warren HS; Simeonovic CJ; Dixon JE; Pembrey RG; Lafferty KJ
Transplant Proc; 1986 Apr; 18(2):310-2. PubMed ID: 3083544
[No Abstract] [Full Text] [Related]
49. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
50. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cells.
Ostrand-Rosenberg S; Clements V; Marr L
Cell Immunol; 1986 Apr; 98(2):257-65. PubMed ID: 3093094
[TBL] [Abstract][Full Text] [Related]
51. Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells.
Heeg K; Wagner H
J Exp Med; 1990 Sep; 172(3):719-28. PubMed ID: 2388033
[TBL] [Abstract][Full Text] [Related]
52. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
Korngold R; Sprent J
J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
[TBL] [Abstract][Full Text] [Related]
53. Lyt-2+ cells sensitized to graft alloantigens trigger the rejection of established cultured pancreatic islet allografts.
Warren HS; Prowse SJ; Agostino M; Lafferty KJ
Transplant Proc; 1984 Aug; 16(4):954-5. PubMed ID: 6431669
[No Abstract] [Full Text] [Related]
54. Murine interstitial nephritis. IV. Long-term cultured L3T4+ T cell lines transfer delayed expression of disease as I-A-restricted inducers of the effector T cell repertoire.
Mann R; Zakheim B; Clayman M; McCafferty E; Michaud L; Neilson EG
J Immunol; 1985 Jul; 135(1):286-93. PubMed ID: 2582035
[TBL] [Abstract][Full Text] [Related]
55. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
Greenberg PD; Kern DE; Cheever MA
J Exp Med; 1985 May; 161(5):1122-34. PubMed ID: 3921652
[TBL] [Abstract][Full Text] [Related]
56. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. II. Immunohistochemical studies on the thyroiditis lesion.
Sugihara S; Maruo S; Tada T; Tsujimura T; Kohno Y; Hamaoka T; Fujiwara H
Reg Immunol; 1989; 2(6):345-54. PubMed ID: 2485683
[TBL] [Abstract][Full Text] [Related]
57. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
Sprent J; Schaefer M; Gao EK; Korngold R
J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
[TBL] [Abstract][Full Text] [Related]
58. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
Shu S; Chou T; Rosenberg SA
Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
[TBL] [Abstract][Full Text] [Related]
59. Effect of in vivo exposure to allogeneic cells upon subsequent in vitro T cell responses and upon allograft rejection.
Cooley MA
Scand J Immunol; 1978; 7(5):371-80. PubMed ID: 149361
[TBL] [Abstract][Full Text] [Related]
60. Antigen-presenting cells for Lyt-2+ cells. I. Stimulation of unprimed Lyt-2+ cells by H-2 different Thy-1-Ia- cells prepared from spleen and bone marrow.
Sprent J; Schaefer M
J Immunol; 1988 Jun; 140(11):3745-50. PubMed ID: 2897393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
